DNA graphic

Financials

The following is an overview of the Lupus Research Alliance’s income and expenditures for the fiscal year ended December 31, 2018.

Revenue & Other Support:
Contributions $15,396,535
Other Support $ 3,616,243
Total Revenue & Other Support: $19,012,778

Program Expenditures:
Research $ 9,608,831
Scientific programs $ 7,064,789
Public policy $ 788,377
Total Program Expenditures: $17,461,997

Administration Expenditures: $1,973,754*
Fundraising Expenditures: $3,179,907*

End of Year Net Asset Balance: $41,261,296

*The LRA’s Supporting Services are covered by donations from its Board of Directors.

As of December 31, 2018, The Lupus Research Alliance has unrestricted financial reserves of approximately $37 million or about 1.6 times its most recent annual expenses, which totaled approximately $23 million. The majority of the $37 million is being held in a board designated endowment in order for the organization to have funds available for special research projects and is designated solely for lupus research.

Click on the following for more information

Read about the programs that support medical breakthroughs